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R primer, to screen 48 individuals (45 of whom were
unrelated) whom we had previously identified as
C282Y homozygotes. In this group, we identified one
additional unrelated individual with the C282Y mu-
tation and the 5569 GrA polymorphism. Closer ex-
amination of the assay on the basis of which the pre-
vious diagnosis was made in this individual revealed
an extremely faint normal band that had been inter-
preted to result from partial digestion. In total, there-
fore, the polymorphism has been found in 8 of 202
unrelated individuals who were referred for HH testing.
An estimate of the allele frequency can be made on the
basis of the C282Y carrier frequency. We found these
8 polymorphism carriers among a total of 43 unrelated
C282Y (non-H63D) carriers. Our estimated popula-
tion frequency of this allele is, therefore, 8/43 (=.186).
Consequently, in our population, this polymorphism
had the potential to result in ∼19% of C282Y heter-
ozygotes being misidentified as homozygotes.
We identified the 8 polymorphism carriers, in addi-
tion to 44 unrelated C282Y homozygotes, from our
total sample of 202 unrelated individuals referred for
testing. If the assumption of homozygosity, along with
access to parental genotypes, had been made in all in-
dividuals with the polymorphism, as well as in those
with the homozygosity, this would have led to an es-
timate of ∼8/52 (=.154) for nonparentage, of which
half of these cases, or 8%, would have been assumed
to result from nonpaternity. The frequency of this poly-
morphism is high enough to warrant concern that the
interpretation of homozygosity in these cases will result
in an overestimate of the C282Y-allele frequency, a mis-
diagnosis of this condition, and an incorrect assump-
tion of nonpaternity in some families. In our hands,
the polymorphism promoted misinterpretation of a re-
striction-digestion–based assay, but any form of anal-
ysis (including allele-specific oligonucleotide hybridi-
zation, ARMS, or direct sequencing) that incorporates
the Feder et al. (1996) reverse primer is equally prone
to misdiagnosis. It is recommended that all laboratories
using the Feder et al. reverse primer to test for the
C282Y mutation confirm C282Y-homozygote results
by using a flanking primer set and MseI digestion.
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No Mutations in the Coding Region of the PRKCG
Gene in Three Families with Retinitis Pigmentosa
Linked to the RP11 Locus on Chromosome 19q
To the Editor:
Retinitis pigmentosa (RP) and allied degenerations of the
retina are genetically heterogeneous, with well over 50
loci implicated so far through gene identifications or
linkage-based chromosomal assignments. Among these
genes, the dominantly inherited RP11 locus (MIM
600138) on chromosome 19q is noteworthy because
some carriers develop RP that is symptomatic at age !20
years, whereas others are asymptomatic and show no
funduscopic or electroretinographic signs of disease even
at age 170 years (Berson et al. 1969; Berson and Si-
monoff 1979; Evans et al. 1995; Nakazawa et al. 1996;
McGee et al. 1997). On the basis of its chromosomal
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assignment, the PRKCG gene is a candidate for RP11.
This gene encodes a form of protein kinase C that is
expressed in the retina. Last year, Al-Maghtheh et al.
(1998) described two families with RP11-linked domi-
nant RP in which a missense change (Arg659Ser) in
PRKCG cosegregated with disease. Only one of these
two families (RP1907) clearly exhibited asymptomatic,
obligate carriers who transmitted the disease to off-
spring. The authors failed to discover a mutation in
PRKCG in three other families with reduced penetrance
showing linkage to this region. Nevertheless, the authors
speculated that PRKCG could be the RP11 gene.
In response to that report, we have undertaken an
analysis of the PRKCG gene in three additional families
with dominant RP with reduced penetrance. All three
families have unaffected, obligate carriers, and we pre-
viously reported linkage data pointing to RP11 as the
cause of RP in these families (McGee et al. 1997). An
affected individual from each family was chosen for the
current study (the patients were individuals III-2 from
family 1295, IV-8 from family 2474, and IV-34 from
family 1562) (McGee et al. 1997), as well as DNA from
an unrelated control individual without RP and without
a family history of retinal degeneration. We amplified
each of the 18 exons of the PRKCG gene individually,
using PCR from leukocyte DNA obtained from these
individuals. Primer pairs were the same as those reported
elsewhere (Al-Maghtheh et al. 1998) except for exons
5, 10, and 11, for which we used primers (sense/anti-
sense) as follows: exon 5, 5′ portion, TGAGGTGCT-
ACCCGCAGCTT / CAGTTACGTGGATCTCATCT;
exon 5, 3′ portion, AGGCTGCGAGATGAACGTGC /
AGGCGAGGGGGCGGGGCCTC; exon 10, GGCT-
GTGTAAGGTCTAAGTG / CACAGGAGCCCAGTCT-
CTTC; exon 11, CTGGGTTCCCAACATGGACT / CT-
TGCCTCTCCCTAAACTCA. The amplified fragments
were sequenced directly by means of standard methods.
None of the patients had a defect in codon 659. Fur-
thermore, none of the patients had an abnormality in
the coding region or the flanking-intron splice-acceptor
or -donor sites, except for one patient who heterozy-
gously carried a silent change in codon 24 (Ala24Ala,
GCTrGCC). In all eight gene copies carried by the three
patients and the control individual, the sequence of co-
dons Phe19 and Ser148 in exons 1 and 5, respectively,
was different from that published elsewhere (TTT in-
stead of TTC, and TCC instead of TCT, respectively),
suggesting that the previously reported sequence
(GenBank accession number M13977) is an allelic var-
iant, a sequencing artifact, or an error. The previously
reported (Al-Maghtheh et al. 1998) silent polymorphism
at codon Asn189 was encountered, with two of the three
patients being heterozygotes (carrying the sequences
AAT and AAC for that codon) and the third patient
being a homozygote for the sequence AAT. We previ-
ously documented a recombination event in the vicinity
of RP11 in one branch of family 1562 (McGee et al.
1997); however, the intragenic polymorphisms were not
informative in this branch of that family and did not
allow us to determine on which side of the crossover the
PRKCG locus lies.
Our analysis provides no evidence that PRKCG is the
RP11 gene. Although our data cannot exclude the path-
ogenicity of the Arg659Ser missense change, the possi-
bility that it is a rare, nonpathogenic variant remains
plausible, since none of the three families analyzed here
and only two of the five families analyzed elsewhere (Al-
Maghtheh et al. 1998) carry an anomaly that would
change the sequence of the encoded protein. Another
formal possibility is that there are two RP genes in this
region, but it would be necessary that both RP loci ex-
hibit reduced penetrance. In either case, it appears that
an RP gene in this region remains to be identified.
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